Literature DB >> 16900409

Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy.

Andrea Rübe1, Sandra Klein, Karsten Mäder.   

Abstract

PURPOSE: The distribution of drugs between water, oil and mixed micelles after the oral application of lipid-based drug delivery systems affects their absorption rate. Since it has not been previously possible to monitor this process online during in vitro lipolysis, it was our aim to develop a suitable real-time method.
MATERIALS AND METHODS: To follow the fate of a co-administered drug during fat digestion, the spin probe tempol benzoate was incorporated as a lipophilic model drug into a long-chain triglyceride (olive oil) and an in vitro digestion test was combined with electron paramagnetic resonance (EPR) spectroscopy (X-Band). Additionally the progression of digestion was determined by means of high performance thin layer chromatography (HPTLC).
RESULTS: The spectral shape of the EPR spectrum changed significantly during the digestion process. EPR spectra at all times could be simulated with three species indicating a redistribution of the lipophilic model drug between olive oil, phosphate buffer and mixed micelles formed by bile salts and phospholipids.
CONCLUSION: This in vitro real-time analysis could be a very helpful tool to monitor the digestibility of novel lipid-based drug nanocarriers which is an important step to optimize and to predict drug delivery processes. In future the EPR monitoring of fat digestion will be transferred to in vivo experiments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16900409     DOI: 10.1007/s11095-006-9069-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium.

Authors:  N H Zangenberg; A Müllertz; H G Kristensen; L Hovgaard
Journal:  Eur J Pharm Sci       Date:  2001-09       Impact factor: 4.384

2.  Simulation of multiple isotropic spin-trap EPR spectra.

Authors:  D R Duling
Journal:  J Magn Reson B       Date:  1994-06

3.  [Bile salts and lipids in aqueous intraluminal phase during the digestion of a standard meal in normal man (author's transl)].

Authors:  M Rautureau; A Bisalli; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1981-04

Review 4.  Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

Authors:  W N Charman; C J Porter; S Mithani; J B Dressman
Journal:  J Pharm Sci       Date:  1997-03       Impact factor: 3.534

5.  On the concentration of bile acids in the human intestine during absorption. Bile acids and sterioids 74.

Authors:  J SJOVALL
Journal:  Acta Physiol Scand       Date:  1959-08-31

6.  Duodenal bile acid concentrations in fat malabsorption syndromes.

Authors:  H Westergaard
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

7.  Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings.

Authors:  J E Staggers; O Hernell; R J Stafford; M C Carey
Journal:  Biochemistry       Date:  1990-02-27       Impact factor: 3.162

Review 8.  Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects.

Authors:  P P Constantinides
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

9.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Agnes Taillardat-Bertschinger; Ben J Boyd; Jacquelyn M O'Connor; Glenn A Edwards; William N Charman
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534

10.  Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.

Authors:  Ann Marie Kaukonen; Ben J Boyd; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more
  5 in total

1.  Self-assembled structures formed during lipid digestion: characterization and implications for oral lipid-based drug delivery systems.

Authors:  Stephanie Phan; Stefan Salentinig; Clive A Prestidge; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

Review 2.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

3.  Effect of ingested lipids on drug dissolution and release with concurrent digestion: a modeling approach.

Authors:  Fulden Buyukozturk; Selena Di Maio; David E Budil; Rebecca L Carrier
Journal:  Pharm Res       Date:  2013-12       Impact factor: 4.200

Review 4.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

Review 5.  Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.

Authors:  Sivacharan Kollipara; Rajesh Kumar Gandhi
Journal:  Acta Pharm Sin B       Date:  2014-10-08       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.